LIVN logo

LivaNova (LIVN) Cash and cash equivalents

annual cash & cash equivalents:

$428.86M+$162.35M(+60.92%)
December 31, 2024

Summary

  • As of today (July 4, 2025), LIVN annual cash & cash equivalents is $428.86 million, with the most recent change of +$162.35 million (+60.92%) on December 31, 2024.
  • During the last 3 years, LIVN annual cash & cash equivalents has risen by +$220.87 million (+106.19%).
  • LIVN annual cash & cash equivalents is now at all-time high.

Performance

LIVN Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLIVNbalance sheet metrics

quarterly cash & cash equivalents:

$738.44M+$309.58M(+72.19%)
March 31, 2025

Summary

  • As of today (July 4, 2025), LIVN quarterly cash & cash equivalents is $738.44 million, with the most recent change of +$309.58 million (+72.19%) on March 31, 2025.
  • Over the past year, LIVN quarterly cash & cash equivalents has increased by +$429.25 million (+138.83%).
  • LIVN quarterly cash & cash equivalents is now at all-time high.

Performance

LIVN quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLIVNbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

LIVN Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+60.9%+138.8%
3 y3 years+106.2%+473.6%
5 y5 years+601.5%+486.9%

LIVN Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+106.2%at high+577.3%
5 y5-yearat high+601.5%at high+577.3%
alltimeall timeat high>+9999.0%at high>+9999.0%

LIVN Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$738.44M(+72.2%)
Dec 2024
$428.86M(+60.9%)
$428.86M(+23.8%)
Sep 2024
-
$346.37M(+5.2%)
Jun 2024
-
$329.24M(+6.5%)
Mar 2024
-
$309.19M(+16.0%)
Dec 2023
$266.50M(+24.4%)
$266.50M(+13.9%)
Sep 2023
-
$233.94M(+4.9%)
Jun 2023
-
$222.94M(+4.0%)
Mar 2023
-
$214.34M(+0.1%)
Dec 2022
$214.17M(+3.0%)
$214.17M(-7.3%)
Sep 2022
-
$231.11M(+112.0%)
Jun 2022
-
$109.02M(-15.3%)
Mar 2022
-
$128.74M(-38.1%)
Dec 2021
$207.99M(-17.7%)
$207.99M(+14.4%)
Sep 2021
-
$181.85M(-44.8%)
Jun 2021
-
$329.39M(+30.4%)
Mar 2021
-
$252.54M(-0.1%)
Dec 2020
$252.83M(+313.5%)
$252.83M(+11.0%)
Sep 2020
-
$227.81M(-2.0%)
Jun 2020
-
$232.55M(+84.8%)
Mar 2020
-
$125.82M(+105.8%)
Dec 2019
$61.14M(+29.5%)
$61.14M(-18.8%)
Sep 2019
-
$75.31M(+69.2%)
Jun 2019
-
$44.51M(-12.3%)
Mar 2019
-
$50.78M(+7.6%)
Dec 2018
$47.20M(-49.6%)
$47.20M(-41.0%)
Sep 2018
-
$79.95M(+68.7%)
Jun 2018
-
$47.38M(-27.1%)
Mar 2018
-
$64.96M(-30.6%)
Dec 2017
$93.61M(+135.3%)
$93.61M(+43.7%)
Sep 2017
-
$65.16M(+52.6%)
Jun 2017
-
$42.69M(-31.9%)
Mar 2017
-
$62.72M(+57.6%)
Dec 2016
$39.79M(-64.7%)
$39.79M(-37.5%)
Sep 2016
-
$63.63M(-0.4%)
Jun 2016
-
$63.89M(-27.0%)
Mar 2016
-
$87.47M(-22.3%)
Dec 2015
$112.61M(-9.3%)
$112.61M(-40.7%)
Oct 2015
-
$189.78M(+16.9%)
Jul 2015
-
$162.36M(+30.7%)
Apr 2015
-
$124.19M(+6.9%)
Apr 2015
$124.19M(+20.2%)
-
Jan 2015
-
$116.21M(-0.5%)
Oct 2014
-
$116.84M(+8.5%)
Jul 2014
-
$107.68M(+4.2%)
Apr 2014
$103.30M(-14.4%)
$103.30M(+12.8%)
Jan 2014
-
$91.60M(-6.3%)
Oct 2013
-
$97.74M(-8.1%)
Jul 2013
-
$106.32M(-11.9%)
Apr 2013
$120.71M(+24.9%)
$120.71M(+3.6%)
Jan 2013
-
$116.53M(-1.7%)
Oct 2012
-
$118.50M(+15.8%)
Jul 2012
-
$102.29M(+5.8%)
Apr 2012
$96.65M(+8.2%)
$96.65M(+23.7%)
Jan 2012
-
$78.14M(+11.9%)
Oct 2011
-
$69.83M(-14.4%)
Jul 2011
-
$81.61M(-8.6%)
Apr 2011
$89.31M(+50.8%)
$89.31M(+4.7%)
Jan 2011
-
$85.27M(+25.6%)
Oct 2010
-
$67.91M(+19.9%)
Jul 2010
-
$56.65M(-4.4%)
Apr 2010
$59.23M(-10.6%)
$59.23M(+8.3%)
Jan 2010
-
$54.68M(-9.6%)
Oct 2009
-
$60.50M(+7.5%)
Jul 2009
-
$56.26M(-15.1%)
DateAnnualQuarterly
Apr 2009
$66.23M(-27.3%)
$66.23M(+5.2%)
Jan 2009
-
$62.93M(-9.2%)
Oct 2008
-
$69.34M(-31.4%)
Jul 2008
-
$101.15M(+11.1%)
Apr 2008
$91.06M(+7.4%)
$91.06M(+1.3%)
Jan 2008
-
$89.92M(+6.7%)
Oct 2007
-
$84.29M(-2.3%)
Jul 2007
-
$86.31M(+1.8%)
Apr 2007
$84.80M(-8.2%)
$84.80M(+0.8%)
Jan 2007
-
$84.15M(-10.5%)
Oct 2006
-
$93.98M(-1.0%)
Jul 2006
-
$94.95M(+2.8%)
Apr 2006
$92.36M(+138.8%)
$92.36M(-7.2%)
Jan 2006
-
$99.49M(-16.3%)
Oct 2005
-
$118.91M(+345.6%)
Jul 2005
-
$26.69M(-31.0%)
Apr 2005
$38.68M(-33.7%)
$38.68M(-30.0%)
Jan 2005
-
$55.26M(+1.5%)
Oct 2004
-
$54.46M(-12.5%)
Jul 2004
-
$62.23M(+6.6%)
Apr 2004
$58.36M(+33.9%)
$58.36M(+1.1%)
Jan 2004
-
$57.71M(+4.3%)
Oct 2003
-
$55.31M(+22.6%)
Jul 2003
-
$45.13M(+3.6%)
Apr 2003
$43.58M(+14.1%)
$43.58M(+10.1%)
Jan 2003
-
$39.56M(+2.5%)
Oct 2002
-
$38.59M(+14.1%)
Jul 2002
-
$33.82M(-11.5%)
Apr 2002
$38.20M(-31.1%)
$38.20M(-11.8%)
Jan 2002
-
$43.33M(-9.0%)
Oct 2001
-
$47.62M(+3.6%)
Jul 2001
-
$45.94M(-19.5%)
Apr 2001
$55.46M(+270.5%)
-
Mar 2001
-
$57.06M(+291.6%)
Dec 2000
-
$14.57M(-2.7%)
Sep 2000
-
$14.98M(+0.1%)
Jun 2000
$14.97M(+869.5%)
$14.97M(+303.0%)
Mar 2000
-
$3.71M(+118.5%)
Dec 1999
-
$1.70M(+70.0%)
Sep 1999
-
$1.00M(-35.2%)
Jun 1999
$1.54M(-9.2%)
$1.54M(+1444.0%)
Mar 1999
-
$100.00K(-50.0%)
Dec 1998
-
$200.00K(-88.9%)
Sep 1998
-
$1.80M(+5.9%)
Jun 1998
$1.70M(+112.5%)
$1.70M(+466.7%)
Mar 1998
-
$300.00K(-98.3%)
Dec 1997
-
$18.10M(-48.6%)
Sep 1997
-
$35.20M(+4300.0%)
Jun 1997
$800.00K(-61.9%)
$800.00K(-88.2%)
Mar 1997
-
$6.80M(+100.0%)
Dec 1996
-
$3.40M(-67.9%)
Sep 1996
-
$10.60M(+404.8%)
Jun 1996
$2.10M(-76.4%)
$2.10M(-51.2%)
Mar 1996
-
$4.30M(-34.8%)
Dec 1995
-
$6.60M(+24.5%)
Sep 1995
-
$5.30M(-40.4%)
Jun 1995
$8.90M(+93.5%)
$8.90M(+56.1%)
Mar 1995
-
$5.70M(+14.0%)
Dec 1994
-
$5.00M(-28.6%)
Sep 1994
-
$7.00M(+52.2%)
Jun 1994
$4.60M(-45.2%)
$4.60M(-59.6%)
Mar 1994
-
$11.40M(+12.9%)
Dec 1993
-
$10.10M(-34.8%)
Sep 1993
-
$15.50M(+84.5%)
Jun 1993
$8.40M
$8.40M(-67.6%)
Mar 1993
-
$25.90M

FAQ

  • What is LivaNova annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for LivaNova?
  • What is LivaNova annual cash & cash equivalents year-on-year change?
  • What is LivaNova quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for LivaNova?
  • What is LivaNova quarterly cash & cash equivalents year-on-year change?

What is LivaNova annual cash & cash equivalents?

The current annual cash & cash equivalents of LIVN is $428.86M

What is the all time high annual cash & cash equivalents for LivaNova?

LivaNova all-time high annual cash & cash equivalents is $428.86M

What is LivaNova annual cash & cash equivalents year-on-year change?

Over the past year, LIVN annual cash & cash equivalents has changed by +$162.35M (+60.92%)

What is LivaNova quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of LIVN is $738.44M

What is the all time high quarterly cash & cash equivalents for LivaNova?

LivaNova all-time high quarterly cash & cash equivalents is $738.44M

What is LivaNova quarterly cash & cash equivalents year-on-year change?

Over the past year, LIVN quarterly cash & cash equivalents has changed by +$429.25M (+138.83%)
On this page